Some investors have concerns that the privatization may fail, but China TCM's privatization seems "mandatory", which will lead to spin-off/integrations ahead. We analyzed the big picture/logic behind
What is covered in the Full Insight:
Investor concerns and Morgan Stanley's target price
Background and the logic of privatization
CNPGC's past actions and newly acquired companies
Chongqing Taiji Industry (Group) A's business structure
Horizontal competition issues and potential resolution
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
Unlock all research summaries
Follow top, independent analysts
Receive personalised alerts and emails
Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.